Corbus reports preliminary cash of $20.9M as of Dec 31, 2023; raised $16.8M via ATM

Corbus Pharmaceuticals Holdings, Inc.

Raised approximately $16.8M in gross proceeds from common stock sales under Open Market Sale Agreement with Jefferies.
Preliminary cash, cash equivalents, and investments of ~$20.9M as of Dec 31, 2023, including $13.7M in cash.
Financial statements for year ended Dec 31, 2023 not yet finalized; amounts subject to adjustments.
Company has not provided any revenue or earnings guidance in this update.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.